Virica Biotech
PrivateLast Round
Grant
Dec 2, 2024
Total Funding Raised
$8.73M
Company Overview
Virica Biotech operates in Healthcare & Life Sciences and is based in Ottawa. Its latest recorded funding round was a Grant round in December 2024.
Virica Biotech is a biotechnology company that develops Viral Sensitizer (VSE™) technology to improve the manufacturing productivity and cost-efficiency of viral medicines, including cell and gene therapies and vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virica Biotech Comparables
Compare Virica Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 64x Bio | 83% | |
| Lentitek | 79% | |
| Virongy Biosciences | 78% |
For institutional investors. Book with your work email.
Virica Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2024 | ||||
| Debt | Jun 24, 2024 | ||||
| Early Funding | Apr 29, 2024 | ||||
| Grant | Jan 22, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
Grant | Apr 21, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Virica Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A |
| Federal Economic Development Agency for Southern Ontario | Debt |
| Ontario Together Fund | Grant |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Innovate UK | Grant |
| Innovation, Science and Economic Development Canada | Grant |
| AyaWas Group | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Launched Viric.AI, an active learning platform for biomanufacturing.
- Apr 16, 2026
Monthly visitors grew 57% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Virica Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Virica Biotech's valuation, stock price, and market status.
Is Virica Biotech a public or private company?
Virica Biotech is a private company.
What is the current stock price of Virica Biotech?
Virica Biotech is a private company, so its shares have no public market price. Caplight tracks Virica Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Virica Biotech worth (valuation)?
Valuation information for Virica Biotech is not publicly available.
Can I buy Virica Biotech stock?
Virica Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Virica Biotech's last funding round?
Virica Biotech's most recent funding round was Grant on December 2, 2024.
Who are the main investors in Virica Biotech?
Key investors in Virica Biotech include Dynamk Capital.
Will Virica Biotech IPO soon?
No public IPO plans have been announced for Virica Biotech.
How can I track Virica Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Virica Biotech's shares on secondary markets.